1
NSG5140 Week 5 Midterm Exam Due 30th September
Complete Actual Exam ACTUAL QUESTIONS AND CORRECT
ANSWERS (VERIFIED ANSWERS) PLUS RATIONALES 2026 Q&A
| INSTANT DOWNLOAD PDF
Core Domains:
1. Advanced Pathophysiology Principles
2. Pediatric Primary Care and Developmental Milestones
3. Acute and Chronic Disease Management
4. Pharmacology and Treatment Protocols
5. Diagnostic Reasoning and Clinical Decision-Making
6. Immunization Schedules and Preventive Care
7. Genetic and Congenital Disorders
8. Infectious Disease Pathophysiology and Management
9. Cardiovascular and Respiratory Pathophysiology
10. Endocrine and Metabolic Disorders
Introduction:
This comprehensive examination is designed to assess advanced knowledge in
pathophysiology and primary care pediatrics, integrating foundational scientific
principles with clinical application. The assessment evaluates the candidate's
ability to analyze complex clinical presentations, apply evidence-based guidelines,
and demonstrate critical thinking in diagnostic and therapeutic decision-making.
Questions encompass a wide range of topics including infectious diseases, genetic
disorders, developmental milestones, immunology, and system-based
pathophysiology. Each scenario-based question requires integration of multiple
knowledge domains and prioritization of patient safety. The examination
emphasizes real-world clinical reasoning, ethical considerations, and adherence to
current practice standards, preparing advanced practice providers for independent
clinical practice.
SECTION ONE: QUESTIONS 1-50
pg. 1
,2
Question 1
A 6-month-old infant is brought to the clinic for a routine well-child visit. The
parents report the infant has been healthy with no significant medical history.
According to the standard childhood immunization schedule recommended by
the CDC, which vaccine should be administered for the first time at this visit, in
addition to continuing the primary series?
A. Inactivated Polio Vaccine (IPV)
B. Hepatitis B (HepB)
C. Diphtheria, Tetanus, and acellular Pertussis (DTaP)
D. Measles, Mumps, and Rubella (MMR)
C. Diphtheria, Tetanus, and acellular Pertussis (DTaP)
RATIONALE: The DTaP primary series is administered at 2, 4, and 6 months of
age, making the 6-month visit the third dose in the series. While IPV and HepB are
also administered during the first six months, they are initiated earlier (HepB at
birth, IPV at 2 months). MMR is not administered until 12-15 months of age. The
6-month visit represents a critical time for completing the primary DTaP series to
ensure adequate protection against pertussis, diphtheria, and tetanus. This timing
is crucial because maternal antibodies have waned, and the infant's immune
system is now capable of mounting a more robust response to the vaccine
antigens. Delaying or missing this dose can compromise the development of
protective immunity and increase susceptibility to these serious vaccine-
preventable diseases. The CDC and AAP provide specific catch-up schedules for
children who fall behind, emphasizing the importance of maintaining
immunization records and adhering to recommended timelines.
Question 2
A 4-year-old child is brought to the emergency department with sudden onset of
a "barking" seal-like cough, inspiratory stridor, and low-grade fever. The child is
alert, playful, and sitting comfortably without drooling. Vital signs reveal mild
tachypnea but stable oxygen saturation. What is the most appropriate initial
management for this child's current respiratory status?
pg. 2
,3
A. Administer a broad-spectrum antibiotic immediately
B. Prescribe oral corticosteroids for home use with reassurance
C. Administer nebulized epinephrine and a dose of oral dexamethasone in the
clinic
D. Refer for urgent tonsillectomy
C. Administer nebulized epinephrine and a dose of oral dexamethasone in the
clinic
RATIONALE: This clinical presentation is classic for moderate croup (viral
laryngotracheobronchitis), the most common cause of stridor in young children.
The presence of stridor at rest indicates moderate severity, warranting immediate
intervention. Nebulized epinephrine (racemic or L-epinephrine) provides rapid
relief of airway edema through alpha-adrenergic vasoconstriction, reducing
mucosal swelling and improving airflow within 10-30 minutes. The effects
typically last 1-2 hours, making it an excellent temporizing measure. Oral
dexamethasone (0.15-0.6 mg/kg) reduces airway inflammation through
glucocorticoid-mediated mechanisms, with effects beginning within 6 hours and
lasting up to 72 hours. This combination addresses both acute symptoms and
underlying inflammation. Antibiotics are ineffective for viral croup, and the child's
alert, playful status without drooling rules out epiglottitis. Oral steroids alone
would be insufficient for stridor at rest, and tonsillectomy is not indicated for
croup. Monitoring for response to treatment is essential, with failure to improve
or worsening respiratory status requiring escalation of care.
Question 3
The American Academy of Pediatrics (AAP) recommends universal screening for
autism spectrum disorder (ASD) using a standardized tool at specific well-child
visits to facilitate early identification and intervention. At which ages should this
formal screening be performed according to AAP guidelines?
A. 2 months and 4 months
B. 6 months and 12 months
C. 18 months and 24 months
D. 3 years and 4 years
pg. 3
, 4
C. 18 months and 24 months
RATIONALE: The AAP recommends formal ASD screening with validated
instruments specifically at the 18-month and 24-month well-child visits. This
targeted screening approach is based on evidence that early identification and
intervention significantly improve developmental outcomes. While
developmental surveillance occurs at every well-child visit through observation
and parental questioning, formal standardized screening is reserved for these
specific ages due to the emergence of characteristic social-communication deficits
during this developmental period. Validated tools such as the M-CHAT-R
(Modified Checklist for Autism in Toddlers, Revised) are specifically designed for
this age range. Screening at 18 months allows for early detection when
neuroplasticity is maximal, while the 24-month screen captures children who may
have milder presentations or later emergence of symptoms. Early intervention
services (Part C) can be initiated promptly when screening identifies concerns,
potentially altering developmental trajectories and improving long-term
outcomes. The AAP emphasizes that screening should be accompanied by
appropriate referral for diagnostic evaluation and early intervention services
when concerns are identified.
Question 4
A 2-week-old infant is brought to the clinic for a weight check. The infant is
breastfeeding well, appears vigorous, and has visible jaundice extending to the
lower extremities. The mother reports good feeding and adequate wet diapers.
Which finding would be most concerning for pathological hyperbilirubinemia
requiring immediate evaluation?
A. Jaundice first appeared on day 3 of life
B. Total serum bilirubin level of 10 mg/dL on day of life 5
C. Jaundice appearing within the first 24 hours of life
D. Infant is breastfed with difficulty latching
C. Jaundice appearing within the first 24 hours of life
pg. 4
NSG5140 Week 5 Midterm Exam Due 30th September
Complete Actual Exam ACTUAL QUESTIONS AND CORRECT
ANSWERS (VERIFIED ANSWERS) PLUS RATIONALES 2026 Q&A
| INSTANT DOWNLOAD PDF
Core Domains:
1. Advanced Pathophysiology Principles
2. Pediatric Primary Care and Developmental Milestones
3. Acute and Chronic Disease Management
4. Pharmacology and Treatment Protocols
5. Diagnostic Reasoning and Clinical Decision-Making
6. Immunization Schedules and Preventive Care
7. Genetic and Congenital Disorders
8. Infectious Disease Pathophysiology and Management
9. Cardiovascular and Respiratory Pathophysiology
10. Endocrine and Metabolic Disorders
Introduction:
This comprehensive examination is designed to assess advanced knowledge in
pathophysiology and primary care pediatrics, integrating foundational scientific
principles with clinical application. The assessment evaluates the candidate's
ability to analyze complex clinical presentations, apply evidence-based guidelines,
and demonstrate critical thinking in diagnostic and therapeutic decision-making.
Questions encompass a wide range of topics including infectious diseases, genetic
disorders, developmental milestones, immunology, and system-based
pathophysiology. Each scenario-based question requires integration of multiple
knowledge domains and prioritization of patient safety. The examination
emphasizes real-world clinical reasoning, ethical considerations, and adherence to
current practice standards, preparing advanced practice providers for independent
clinical practice.
SECTION ONE: QUESTIONS 1-50
pg. 1
,2
Question 1
A 6-month-old infant is brought to the clinic for a routine well-child visit. The
parents report the infant has been healthy with no significant medical history.
According to the standard childhood immunization schedule recommended by
the CDC, which vaccine should be administered for the first time at this visit, in
addition to continuing the primary series?
A. Inactivated Polio Vaccine (IPV)
B. Hepatitis B (HepB)
C. Diphtheria, Tetanus, and acellular Pertussis (DTaP)
D. Measles, Mumps, and Rubella (MMR)
C. Diphtheria, Tetanus, and acellular Pertussis (DTaP)
RATIONALE: The DTaP primary series is administered at 2, 4, and 6 months of
age, making the 6-month visit the third dose in the series. While IPV and HepB are
also administered during the first six months, they are initiated earlier (HepB at
birth, IPV at 2 months). MMR is not administered until 12-15 months of age. The
6-month visit represents a critical time for completing the primary DTaP series to
ensure adequate protection against pertussis, diphtheria, and tetanus. This timing
is crucial because maternal antibodies have waned, and the infant's immune
system is now capable of mounting a more robust response to the vaccine
antigens. Delaying or missing this dose can compromise the development of
protective immunity and increase susceptibility to these serious vaccine-
preventable diseases. The CDC and AAP provide specific catch-up schedules for
children who fall behind, emphasizing the importance of maintaining
immunization records and adhering to recommended timelines.
Question 2
A 4-year-old child is brought to the emergency department with sudden onset of
a "barking" seal-like cough, inspiratory stridor, and low-grade fever. The child is
alert, playful, and sitting comfortably without drooling. Vital signs reveal mild
tachypnea but stable oxygen saturation. What is the most appropriate initial
management for this child's current respiratory status?
pg. 2
,3
A. Administer a broad-spectrum antibiotic immediately
B. Prescribe oral corticosteroids for home use with reassurance
C. Administer nebulized epinephrine and a dose of oral dexamethasone in the
clinic
D. Refer for urgent tonsillectomy
C. Administer nebulized epinephrine and a dose of oral dexamethasone in the
clinic
RATIONALE: This clinical presentation is classic for moderate croup (viral
laryngotracheobronchitis), the most common cause of stridor in young children.
The presence of stridor at rest indicates moderate severity, warranting immediate
intervention. Nebulized epinephrine (racemic or L-epinephrine) provides rapid
relief of airway edema through alpha-adrenergic vasoconstriction, reducing
mucosal swelling and improving airflow within 10-30 minutes. The effects
typically last 1-2 hours, making it an excellent temporizing measure. Oral
dexamethasone (0.15-0.6 mg/kg) reduces airway inflammation through
glucocorticoid-mediated mechanisms, with effects beginning within 6 hours and
lasting up to 72 hours. This combination addresses both acute symptoms and
underlying inflammation. Antibiotics are ineffective for viral croup, and the child's
alert, playful status without drooling rules out epiglottitis. Oral steroids alone
would be insufficient for stridor at rest, and tonsillectomy is not indicated for
croup. Monitoring for response to treatment is essential, with failure to improve
or worsening respiratory status requiring escalation of care.
Question 3
The American Academy of Pediatrics (AAP) recommends universal screening for
autism spectrum disorder (ASD) using a standardized tool at specific well-child
visits to facilitate early identification and intervention. At which ages should this
formal screening be performed according to AAP guidelines?
A. 2 months and 4 months
B. 6 months and 12 months
C. 18 months and 24 months
D. 3 years and 4 years
pg. 3
, 4
C. 18 months and 24 months
RATIONALE: The AAP recommends formal ASD screening with validated
instruments specifically at the 18-month and 24-month well-child visits. This
targeted screening approach is based on evidence that early identification and
intervention significantly improve developmental outcomes. While
developmental surveillance occurs at every well-child visit through observation
and parental questioning, formal standardized screening is reserved for these
specific ages due to the emergence of characteristic social-communication deficits
during this developmental period. Validated tools such as the M-CHAT-R
(Modified Checklist for Autism in Toddlers, Revised) are specifically designed for
this age range. Screening at 18 months allows for early detection when
neuroplasticity is maximal, while the 24-month screen captures children who may
have milder presentations or later emergence of symptoms. Early intervention
services (Part C) can be initiated promptly when screening identifies concerns,
potentially altering developmental trajectories and improving long-term
outcomes. The AAP emphasizes that screening should be accompanied by
appropriate referral for diagnostic evaluation and early intervention services
when concerns are identified.
Question 4
A 2-week-old infant is brought to the clinic for a weight check. The infant is
breastfeeding well, appears vigorous, and has visible jaundice extending to the
lower extremities. The mother reports good feeding and adequate wet diapers.
Which finding would be most concerning for pathological hyperbilirubinemia
requiring immediate evaluation?
A. Jaundice first appeared on day 3 of life
B. Total serum bilirubin level of 10 mg/dL on day of life 5
C. Jaundice appearing within the first 24 hours of life
D. Infant is breastfed with difficulty latching
C. Jaundice appearing within the first 24 hours of life
pg. 4
